Skip to main content
Fig. 4 | Infectious Diseases of Poverty

Fig. 4

From: Epidemiological survey and genetic characterization of type 3 vaccine-derived poliovirus isolated from a patient with four doses of inactivated polio vaccine in Henan Province, China

Fig. 4

Alignment of amino acid residues of neutralizing antigenic (NAg) sites. NAg1 (VP1: 88–106), NAg2 (VP2: 163–172; VP2: 268–270; VP1: 222–227), NAg3a (VP3: 54–61; VP3: 70–74; VP1: 287–291), and NAg3b (VP2: 71–73; VP3: 75–80) were identified in Sabin 3 (GenBank accession no. AY184221), Henan type 3 VDPVs, and the type 3 wild poliovirus prototype strain P3/Leon/37 (GenBank accession no. K01392). NAg neutralizing antigenic, VP1 viral protein 1, VP2 viral protein 2, VP3 viral protein 3

Back to article page

Infectious Diseases of Poverty

ISSN: 2049-9957

Contact us